Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, is featuring its new TB diagnostic test, the Clearview TB ELISA, at the International AIDS conference (AIDS 2008). The test, which was introduced to developing world markets in July 2008, provides a much needed aid in the diagnosis of Mycobacterium tuberculosis (TB) in TB/HIV co-infected patients.

More: continued here

This entry was posted on Monday, August 11th, 2008 at 8:08 am and is filed under Conferences. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.